- -


                   Nation's Largest Fertility-Services Company
             No. 13 on Fortune's Fastest Growing Small Business List

PURCHASE, NEW YORK - IntegraMed America, Inc. (Nasdaq: INMD), the largest
fertility-services company in the United States, today announced its ranking at
no. 13 on the Fortune Small Business magazine's fourth annual list of 100
fastest growing publicly traded small companies in America, according to the
July issue.

"IntegraMed's ranking on this prestigious list of small public companies is a
reflection of the value of our services to the fertility community," said
Gerardo Canet, Chairman/ CEO of IntegraMed America, Inc. "Consistently focusing
on providing the fertility community with superior products and services has
allowed us to achieve the year over year growth now recognized by Fortune."

IntegraMed is appearing on the Fortune list of fastest growing small companies
for the second consecutive year. Last year, IntegraMed debuted at no. 24 on the
list.

The Fortune ranking is based on earnings growth, revenue growth and stock
performance over the last three years. Companies that qualify for consideration
by Fortune Small Business have less than $200 million in annual revenues.

IntegraMed, based in Purchase, NY offers products and services to patients,
providers and payors focused on the $2 billion fertility industry. IntegraMed
provides business services to a national network of fertility centers;
distributes pharmaceutical products and treatment financing programs directly to
consumers; and operates http://www.integramed.com, a leading fertility portal.
                                       ###

===============================================================================

Statements contained in this press release that are not based on historical
fact, including statements concerning future results, performance, expectations
and expansion of IntegraMed are forward-looking statements that may involve a
number of risks and uncertainties. Actual results may differ materially from the
statements made as a result of various factors, including, but not limited to,
the risks associated with IntegraMed's ability to finance future growth; the
loss of significant business services contract(s); profitability at Reproductive
Science Centers serviced by IntegraMed; changes in insurance coverage,
government laws and regulations regarding health care or managed care
contracting; and other risks, including those identified in the IntegraMed's
most recent Form 10-K and in other documents filed by IntegraMed with the U.S.
Securities and Exchange Commission. All information in this press release is as
of June 28, 2004 and IntegraMed undertakes no duty to update this information.